Nisa Investment Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARCT
AIM
NAMA
Nisa Investment Advisors's ARCT Position: Q4 2025 in Review
Nisa Investment Advisors sold out of Arcturus Therapeutics (ARCT) in Q4 2025, closing a stake of 1,422 shares — an estimated $26.2K sold.
Nisa Investment Advisors first reported a position in ARCT in Q4 2020 and held it in 20 quarters. The position peaked at $43K in Q4 2020. 120 funds tracked by Wall St. Rank hold ARCT as of Q4 2025.
- Nisa Investment Advisors reported no remaining Arcturus Therapeutics position as of Q4 2025 after selling out during the quarter.
- Nisa Investment Advisors sold 1,422 Arcturus Therapeutics shares in Q4 2025, an estimated $26.2K.
- Nisa Investment Advisors first reported a position in Arcturus Therapeutics in Q4 2020 and held it in 20 quarters.
- Nisa Investment Advisors's Arcturus Therapeutics position peaked at $43K in Q4 2020.
- 120 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2025.
Based on Nisa Investment Advisors's 13F filing for Q4 2025, filed 15 Jan 2026.